Canadian Blood Services stopped collecting enough plasma on our behalf, which is why we have been importing 70% of our medication from the United States. There is no “shortage of plasma” in Canada.
Canadian Blood Services started to buy a majority of our plasma-based medication from the US because it was cost-effective. This decision has made us over-reliant on foreign plasma product. If there is a disruption in the US supply chain, Canadians would not have access to our own product because we haven’t secured a strong plasma donor pool.
Private paid plasma in Canada doesn’t help change this. It creates competition.
If the source to self-sufficiency is Canadian veins, it is the sole responsibility of CBS to collect it